Medigus Ltd Sponsored

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Leading drone company using ParaZero's SafeAir™ system is heading towards completing final regulatory process of type certification with the U.S. Federal Aviation Administration (FAA) Leading drone company using ParaZero's SafeAir™ system is heading towards completing final regulatory process of type certification with the U.S. Federal Aviation Administration (FAA)

Medigus Announces Final Airworthiness Criteria Published by the FAA

Medigus expects to consolidate Gix Internet's financial results during 2022

Medigus: Gix Internet Reports Over $45 Million in Revenues for 2021

ParaZero's unique patented technology designed to prevent drone crashes and losses

Leading Global Drone Manufacturer Orders Customized SafeAirTM System from Medigus‘ ParaZero Subsidiary

Charging Robotics signs LOI to complete reverse merger on OTC Markets

Medigus Announces Details of Planned Spin-Off and Subsequent Merger of its EV Wireless Charging Business

Tel Aviv, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Revoltz, an EV and wireless charging joint venture, of which Medigus owns 19.9% and which is operated through the Company's wholly owned subsidiary, Charging Robotics Ltd., will start a pilot project at a new fully autonomous supermarket in Israel.

Medigus' Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program at a New Autonomous Supermarket

Prof. Agmon-Levin serves as the Head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic at Sheba Medical Center - Tel HaShomer, Israel

Medigus: Prof. Nancy Agmon-Levin Joins Polyrizon's Scientific Advisory Board

Tel Aviv, Israel, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 47.69% owned subsidiary, Eventer Technologies Ltd. (“Eventer”), a developer of a technology platform enabling producers and venues to create virtual conferences and events including a smart ticketing solution, signed contracts with the Israel Gymnastics Federation and Table Tennis Association.

Medigus Subsidiary, Eventer, Signs Contracts With the Israel Gymnastics Federation and the Table Tennis Associations of Israel

Tel Aviv, Israel, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its wholly-owned subsidiary, Charging Robotics Ltd. and BGN Technologies, the technology transferred company of Ben-Gurion University signed an agreement to develop the next generation of Charging Robotics' wireless charging system for electric vehicles.

Medigus: Charging Robotics and Ben-Gurion University to Develop the Next Generation of Wireless Charging System for Electric Vehicles

Tel Aviv, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that ParaZero Ltd. ("ParaZero"), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40% ownership stake, confirmed that a drone carrying its ParaZero SafeAirTM system was granted the first authorization for commercial drone deliveries from The Brazilian National Civil Aviation Agency (ANAC).

Medigus Announces First Authorization For Commercial Drone Deliveries in Brazil

The drone company's p atented technology is a unique solution to prevent drone crashes and losses

Medigus Invests in Drone Safety Technology Company with Industry Changing Solution

Tel Aviv, Israel, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that an interview with Chairman Eli Yoresh and Vice President of Strategy and Business Development Yaki Baranes will air on The RedChip Money Report® on Bloomberg TV, Jan. 29, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the United States.

Medigus Ltd. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Tel Aviv, Israel, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 47.69% owned subsidiary, Eventer Technologies Ltd. ( “Eventer”), software company engaged in the development and operation of a technology platform, based on cloud computing, for the management of ticketing sales for in-person, virtual (events which occur and are broadcast over a digital platform over the internet), and hybrid events (events that allow both in-person and virtual participation) of various types, including performances, festivals, courses, lectures, conferences and different activities, confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to a potential initial public offering of its ordinary shares in the United States. The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined.

Medigus: Eventer Technologies Ltd. Submitted Confidential Draft Registration Statement for the Proposed U.S. Initial Public Offering

In recent pre-clinical studies, Polyrizon products demonstrated a great potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death In recent pre-clinical studies, Polyrizon products demonstrated a great potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death

Medigus: Polyrizon to Test its Product Candidate for Protection Against the Highly Transmissible Corona Virus Omicron Variant

Tel Aviv, Israel, Dec. 01, 2021 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced it had filed a motion seeking a court approval for a capital reduction of up to $3 million for the Company's buyback program, increasing the contemplated program from $2 million to $3 million.

Medigus Filed a $3 Million Buyback Program

Tel Aviv, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 50.03% owned subsidiary, Jeffs' Brands Ltd., a data-driven e-commerce company operating on the Amazon Marketplace, confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to a potential initial public offering of its ordinary shares in the United States. The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined.

Medigus: Jeffs' Brands Submitted Confidential Draft Registration Statement for Proposed U.S. Initial Public Offering

Charging Robotics wireless technology and operational concept are in lined with The Bipartisan Infrastructure Deal's EV vision of “…provide convenient charging where people live, work, and shop”

Charging Robotics Celebrates the Historic $1.2 Trillion Bipartisan Infrastructure Bill with an Estimated $7.5 Billion to Build Out a National Network of EV Charges

The successful procedure, performed by Golden Grand and broadcasted live on Chinese TV, will support the Company's campaign to obtain additional licensing and sale agreements world-wide. Golden Grand payments to Medigus to total $2.4 million

Medigus Achieved Major Milestone of Successful Procedure in China Using FDA Approved MUSE™ System

Both Positions Will Focus on Advancing ScoutCam's Expansion Strategy in the Industry 4.0 Markets Both Positions Will Focus on Advancing ScoutCam's Expansion Strategy in the Industry 4.0 Markets

Medigus: ScoutCam Rounds Out Management Team with Appointments of Arik Priel as Chief SW Architect and Roee Peled as VP Business Development

Polyrizon tested its Capture and Contain (C&C™) proprietary hydrogel technology against house dust mite allergen and Timothy grass pollen allergen in cell culture assays

Medigus: Polyrizon Innovative Technology Demonstrated it may Prevent Allergic Reaction Caused by Common Allergens

BEST Inc - ADR

New Oriental Education & Technology Group

Which penny stocks are you watching next week? The post 3 Penny Stocks to Watch in the First Week of November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks to Watch in the First Week of November

Medigus and Safee ' s JV will engage in the purchase and sale of non-fungible tokens and other digital assets

Medigus to Form New Joint Venture to Trade NFT Assets, Investing up to $5M

Polyrizon engaged with a Contract Research Organization to oversee Polyrizon's efforts for U.S FDA submission of its coronavirus and allergen preventative products

Medigus: Polyrizon to Initiate Processes Towards FDA Submission

Cortex's revenues for H1 2021 amounted to approximately $13.5 million, an increase of 53% compared to H1 2020 Cortex's revenues for H1 2021 amounted to approximately $13.5 million, an increase of 53% compared to H1 2020

Medigus: Gix Completed Acquisition of Leading Media-Tech Company Cortex Group for Approximately $11 Million

Medigus to invest $400,000 in Safee, an NFT-based ownership social network aiming to bring its unique technology to mass market creators and audiences

Medigus Enters NFT Space with a First Investment in Blockchain Company Safee

Tel Aviv, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced it has completed a corporate rebranding process, including but not limited to, a new brand logo, a new website and an investor lobby,  http://www.medigus.com/.

News for Medigus Ltd Sponsored Stock (MDGS)